Skip to main content

Research portfolio

Our portfolio spans a range of methodologies and types of research. Some of our studies are highlighted below.

StudyTitleOur roleStatus
COBraPatient reported core outcomes in brain tumour trialsChief-Investigator: Anthony ByrneOngoing
BeCOVIDThe grief experiences and support needs of people bereaved during the COVID-19 pandemicChief Investigator:
Emily Harrop; Lucy Selman
PhABBarriers to and facilitators of physical activity in cancer patients with brain tumours in Wales and BangladeshChief Investigator: Ishrat IslamOngoing
ChronosComparative health research outcomes of novel surgery in prostate cancer: A phase II randomised controlled trial incorporating an internal pilotCo-Investigators: Mirella Longo, Annmarie NelsonOngoing
RamboResearch assessment outcome measures for malignant bowel obstructionChief Investigator: Simon NobleOngoing
Cochrane ReviewEarly palliative interventions for improving outcomes in people with a primary malignant brain tumour and their carers: a Cochrane ReviewChief Investigator: Anthony ByrneOngoing
Marie Curie StudentshipDeveloping a screening tool for the effects of radiation therapy for brain cancerPhD Student: Francesca MazzaschiOngoing
GirasolDevelopment of guidelines for the communication of research results to patients,  members of the public and other stakeholder groupsChief Investigator: Mirella LongoOngoing
EmpowerEvaluating a patient designed tool to reduce harm from cancer associated thrombosis (CAT)Chief Investigator: Simon NobleReporting stage
Bereavement Support ServicesA scoping survey of bereavement support services in WalesChief Investigators: Anthony Byrne, Emily HarropReported
7 Day EvaluationAn evaluation of the Cardiff and Vale University Healthboard weekend and bank holiday specialist palliative care clinical nurse specialist serviceChief Investigator: Alisha NewmanReported
ROCSPalliative radiotherapy in addition to self expanding metal stent for improving outcomes of dysphagia and survival in advanced oesophageal cancerCo-Chief Investigator: Anthony Byrne

Lancet Gastro & Hepatology

J Clin Oncology